{"id":"df43b0c3-7ee5-4ba3-ad84-f324d4645dc5","arxiv_id":"2607.07725","paper_version":1,"verdict":"CONDITIONAL","confidence":"MODERATE","novelty_score":6.0,"correctness_risk":"medium","formal_verification":"none","parameter_count":5,"one_line_summary":"A masked-attention survival model trained with variable-rate feature masking predicts from incomplete genomic panels without imputation and transfers across institutions with mismatched gene sets.","lead":"SHIFT is a transformer that predicts cancer survival from incomplete gene panels without filling in missing values. It matters because hospitals use different sequencing tests, so models that need a fixed gene list often fail when moved between centers.","discovery_kind":"new_method","skeptic_critique":{"model":"grok-4.5","headline":"The headline gains under severe panel mismatch rest on a single small external cohort and modest C-index differences without formal uncertainty quantification.","rationale":"The reader correctly flags that random VRM (Sec. 3.3) is only a proxy for fixed institutional panel blocks, and the paper itself notes this limitation. That is a real design gap, but it is secondary: even under the paper’s own random-masking regime the decisive external numbers are small-n ensemble C-indices without uncertainty. The architecture and no-imputation story remain sensible and the control experiments (aligned features, 22-feature shared set) are informative; the soft spot is whether the reported edges are stable enough to support “matches or beats imputation under severe mismatch” and “incomplete cohorts improve external performance.” Strengthening statistics (or releasing code for re-runs) would convert CONDITIONAL into a clearer accept-shaped contribution; the concern does not justify REJECT. I therefore keep the reader’s CONDITIONAL verdict while shifting emphasis from the masking-proxy assumption to the statistical fragility of the key tables.","tokens_in":15502,"tokens_out":621,"duration_ms":5988,"concrete_test":"Re-train SHIFT-VRM and the top two imputed baselines (CoxPH+mean, RSF+mean) with ≥10 independent random seeds (or bootstrap the 5-fold ensembles) on the same TCGA splits; report mean±std and 95% CIs for Ens-All C-index on US and CPTAC, plus a paired test of SHIFT-VRM vs CoxPH+mean on US and of TCGA-only vs TCGA+US on CPTAC. If the US gap vs CoxPH and the CPTAC lift both lose significance or shrink below ~0.01, the central multi-center claim weakens.","verdict_should_be":"CONDITIONAL","load_bearing_attack":"The strongest claim is that one SHIFT-VRM model remains competitive under severe structural missingness (175/197 LUSC features absent) and can even improve external performance when incomplete cohorts are included in training. That claim is load-bearing on Tables 3–5, where the decisive numbers are Ens-All C-indices on the private US cohort (n=102) and CPTAC (n=101). SHIFT-VRM reaches 0.570 Ens-All on US (no imputation), matching CoxPH+mean (0.570) and beating most KNN/mean baselines; adding the incomplete US cohort then lifts CPTAC Ens-All from 0.602 to 0.629. These are single-point ensemble scores from 5 folds on small external sets, with no confidence intervals, no paired significance tests, and no multi-seed variance. The Discussion itself flags limited statistical testing and modest external sizes. If the 0.02–0.03 C-index edges are within fold-to-fold or seed noise, the practical superiority over imputation and the “incomplete cohorts help” claim are not yet secured.","agreement_with_reader":"partial"},"referee_report":{"model":"grok-4.5","summary":"The paper proposes SHIFT, a transformer-based discrete-time survival model for incomplete genomic inputs. Each genomic feature is embedded by a dedicated SNN block, a binary availability mask is used as a key-padding mask so that self-attention aggregates only observed features into a [CLS] token, and predictions are made without test-time imputation. Training uses variable-rate feature masking (VRM) that randomly drops up to a fraction f of features per sample. Experiments cover GBM (36 shared features; TCGA development, CPTAC and German external) and LUSC (197 features in TCGA/CPTAC vs 22 in a private US cohort, i.e., 88.8% structural absence). Baselines include CoxPH, RSF, XGBoost-Cox, DeepSurv, DeepHit, and SNN, with KNN/mean imputation where needed. Reported results claim that SHIFT-VRM is competitive on fully aligned panels, matches or beats imputed baselines under severe panel mismatch (US Ens-All 0.570 without imputation), and that adding the incomplete US cohort during training improves CPTAC Ens-All from 0.602 to 0.629.","tokens_in":15851,"tokens_out":910,"duration_ms":13743,"significance":"If the claims hold under stronger statistical scrutiny, the work is practically significant for multi-center precision oncology: structural panel mismatch is a real deployment barrier, and a single missingness-aware model that avoids test-time imputation and can retain incomplete cohorts is a useful alternative to shared-feature restriction or site-specific models. Strengths include a coherent architecture (feature-wise tokens + attention mask + discrete-time NLL), a clear experimental ladder (complete-data control, severe-mismatch inference, shared-feature control, multi-site training, and f-ablation), and external validation on two cancers. The contribution is more applied and systems-level than foundational: masked attention for incomplete tabular inputs is known, and VRM is a free design choice; the value lies in the survival setting, the severe structural-missingness evaluation, and the inclusive multi-center training result.","major_comments":[{"comment":"Tables 3–5 are load-bearing for the central claims (parity under 175/197 missing features; incomplete cohorts improve external performance), but all decisive numbers are single-point Ens-All/Top-3 C-indices on small external sets (US n=102, CPTAC n=101) without confidence intervals, multi-seed variance, or paired significance tests. Differences of ~0.02–0.03 (e.g., CPTAC Ens-All 0.602→0.629; US match to CoxPH+mean at 0.570) may be within fold/seed noise. The Discussion acknowledges limited statistical testing and modest external sizes; these claims need bootstrap CIs and/or paired tests (or multi-seed ensembles) before superiority or “incomplete cohorts help” can be treated as secured.","section":null},{"comment":"Sec. 3.3 defines VRM as ki ~ Uniform{0,…,⌊f·d⌋} with random feature indices; the Discussion notes that real panel mismatch is often fixed and site-structured rather than random. The transfer claim—that robustness under random absence generalizes to institutional block missingness—is therefore an untested assumption for the LUSC US setting. A load-bearing control would train with structured/block masks that mimic panel subsets (or leave-one-panel-out style masks) and re-evaluate US/CPTAC; without that, the reported external gains may overstate robustness to real deployment missingness.","section":null},{"comment":"Table 4’s shared 22-feature control shows SHIFT w/o VRM is not superior on the reduced panel (Ens-All 0.494 vs SNN 0.528), while SHIFT-VRM’s advantage is reported only when trained on all 197 features and applied natively. This is a useful design point, but the manuscript should more carefully separate architecture benefit from “train on richer panels + mask at deploy” benefit, and report the same uncertainty quantification on the 22-feature baselines so the full-feature advantage is not overstated relative to the standard lowest-common-denominator practice.","section":null}],"minor_comments":[],"recommendation":"major_revision","confidential_remarks":null},"author_rebuttal":null,"desk_editor":{"model":"grok-4.5","letter":"The useful takeaway is simple: a single masked-attention discrete-time survival model with variable-rate feature masking can train and deploy across mismatched genomic panels without test-time imputation, stay competitive when features are complete, and let incomplete cohorts contribute during development. That combination is the actual contribution.\n\nWhat is new is not masked attention itself (Caruso et al. and time-series work already do versions of it) or discrete-time survival (DeepHit/SNN lineage). It is the packaging for structural panel mismatch in genomics: feature-wise SNN tokens, key-padding mask so missing tokens never enter attention, VRM as both missingness simulation and regularizer, and the explicit multi-center experiments. The design is coherent. The shared-feature control (Table 4) and f-ablation (Table 6) are the right checks. On LUSC US with 175/197 features gone, SHIFT-VRM hits Ens-All 0.570 without imputation and matches the best mean-imputed CoxPH while beating most other baselines. Adding the incomplete US patients then lifts CPTAC Ens-All from 0.602 to 0.629. Those numbers support the practical claim that you do not have to throw incomplete cohorts away.\n\nSoft spots are real but proportionate. External cohorts are small (US n=102, CPTAC n=101). The headline edges are 0.02–0.03 C-index points from 5-fold ensembles with no CIs, no paired tests, and no multi-seed variance. The Discussion already flags this. Random VRM is only a proxy for fixed institutional missing blocks; if real panel structure differs, transfer may shrink. Private data and no code limit re-running. None of that breaks the argument; it just means the superiority claim is not yet locked down.\n\nMath and loss are standard discrete-time NLL with a fixed β=0.6; citations are appropriate and not circular. This is for people building multi-center clinical ML systems who actually face panel heterogeneity. It is not a biology paper and not a paradigm shift.\n\nI would send it to peer review. A serious referee can demand better statistics, public code, and a clearer statement of the random-vs-structured masking gap. Worth engaging if you work on deployable survival models.","headline":"Solid applied methods paper on a real multi-center genomics problem; gains under severe panel mismatch are real but rest on small external n and modest C-index edges without formal uncertainty.","tokens_in":16437,"tokens_out":563,"would_cite":true,"duration_ms":5793,"reading_group":"maybe","serious_thinker":"yes","would_accept_peer_review":true},"rs_alignment":null,"lean_confirmation":null,"pith_extraction":{"msc":[],"pacs":[],"model":"grok-4.5","headline":"A single transformer can predict cancer survival from incomplete gene panels without filling in missing values.","keywords":["survival prediction","incomplete genomic data","structural missingness","masked transformer","variable-rate feature masking","multi-center oncology","precision oncology"],"falsifier":"Train SHIFT with random VRM, then evaluate on an external cohort whose missing genes form a fixed institutional panel that was never seen during training; if concordance falls below the best mean-imputed baseline on that panel, the transfer claim fails.","tokens_in":16393,"feed_emoji":"🧬","tokens_out":563,"duration_ms":5341,"temperature":0.7,"pith_summary":"Genomic survival models usually break when hospitals measure different gene sets: either you throw out patients, shrink to the shared genes, or impute the rest. This paper introduces SHIFT, a transformer that treats each gene as its own token and uses a missingness mask so attention only looks at genes that were actually measured. During training it randomly hides different fractions of features so the model learns to work from partial panels. On glioblastoma and lung squamous cell carcinoma, including a hard external set missing nearly 89% of features, SHIFT matches or beats standard survival models that rely on imputation, while keeping one model for all panels. Including incomplete cohorts in training can even improve performance on fully observed external data. The practical claim is that multi-center genomic survival prediction can be done without forcing every site onto the same assay.","feed_headline":"One model predicts survival across mismatched gene panels","feed_subtitle":"A masked transformer skips imputation and still holds up when nearly 90% of features are missing","key_machinery":"SHIFT: each genomic feature is embedded as its own token; a binary availability mask excludes missing tokens from self-attention so the class token aggregates only observed genes; variable-rate masking (VRM) randomly hides up to a fraction f of features each training sample to build robustness to heterogeneous panels.","core_discovery":"SHIFT shows that a missingness-aware transformer, trained with variable-rate feature masking, can predict survival directly from incomplete genomic inputs without test-time imputation, remain competitive when all features are present, and match or outperform imputation-based baselines under severe cross-cohort panel mismatch, while allowing incomplete cohorts to contribute useful signal during model development.","pith_inferences":[],"forward_implications":[],"fun_headline_variants":["Masked transformer predicts survival across mismatched gene panels","SHIFT handles incomplete genomics without test-time imputation","One model survives severe cross-cohort feature panel mismatch","Variable-rate masking trains survival model on partial gene data","Incomplete cohorts improve external multi-center survival forecasts"],"cache_read_input_tokens":128,"weakest_assumption_plain":"The paper assumes that randomly hiding different numbers of genes during training is a good enough stand-in for the fixed, institution-specific blocks of genes that real sequencing panels leave out.","fun_headline_variants_meta":{"raw":{"variants":["Masked transformer predicts survival across mismatched gene panels","SHIFT handles incomplete genomics without test-time imputation","One model survives severe cross-cohort feature panel mismatch","Variable-rate masking trains survival model on partial gene data","Incomplete cohorts improve external multi-center survival forecasts"]},"model":"grok-4.5","effort":"low","cost_usd":0.004484,"raw_usage":{"total_tokens":1328,"prompt_tokens":775,"num_sources_used":0,"completion_tokens":56,"cost_in_usd_ticks":44840000,"prompt_tokens_details":{"text_tokens":775,"audio_tokens":0,"image_tokens":0,"cached_tokens":256},"completion_tokens_details":{"audio_tokens":0,"reasoning_tokens":497,"accepted_prediction_tokens":0,"rejected_prediction_tokens":0}},"tokens_in":775,"tokens_out":56,"duration_ms":4054,"temperature":1.0,"reasoning_tokens":497,"cache_read_input_tokens":256,"cache_creation_input_tokens":0},"cache_creation_input_tokens":0},"created_at":"2026-07-11T22:11:38.092139+00:00","model_set":{"reader":"grok-4.5"},"falsifier":"Train SHIFT with random VRM, then evaluate on an external cohort whose missing genes form a fixed institutional panel that was never seen during training; if concordance falls below the best mean-imputed baseline on that panel, the transfer claim fails.","supporting_citations":[],"review_version":1}